New Meta-Analysis Demonstrates that Access to the GeneSight Test Can Significantly Improve Response and Remission Rates for Patients with Depression - Candlesense

MYR Clinical trials

New Meta-Analysis Demonstrates that Access to the GeneSight Test Can Significantly Improve Response and Remission Rates for Patients with Depression

Published September 03, 2025 at 08:30 PM

(MYR) Results published in the Journal of Clinical Psychopharmacology Results published in the Journal of Clinical Psychopharmacology